Stories Library

February 12, 2019

By: Alan Shuldiner, Vice President, Strategic Research Initiatives, Regeneron Genetics Center

Genetic 'founder populations' such as the Amish community help scientists accelerate their research, often enabling discoveries that can help improve health in these very same populations.

Genetics

January 17, 2019

By: George Yancopoulos, MD, PhD, President and Chief Scientific Officer

How does society overcome the challenges of disease, food insecurity and climate change? We think one way is through support of the Regeneron Science Talent Search, where passionate, skilled young people bring fresh perspectives to significant global problems.

Responsibility & Culture

November 05, 2018

By: George Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
Len Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer

The current view of the biopharma industry tends to focus on short-term issues. But, we fear there are even more important longer-term threats to human health at stake and encourage people to understand why investment in innovation is more important than ever.

Research & Preclinical Development

October 31, 2018

By: Neil Stahl, PhD, Executive Vice President, Research and Development

Twenty-five years of discovery and development of medicines at Regeneron have helped millions of people. Leveraging the power of collaboration, we are now working on a medicine to treat Ebola. This is the story of REGN-EB3; a drug we hope no one will ever need.

Clinical Research & Medicines

October 29, 2018

By: Jeffrey Reid, PhD, Vice President, Chief Data Officer, Regeneron Genetics Center®

Want a revolution in genomics? Pair lightning-fast, computational pattern recognition with an unprecedented amount of health data. Regeneron Genetics Center^® (RGC) is leveraging the power of artificial intelligence and machine learning to do just that.

Genetics